Faculty profile

Tianru Jin

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Tianru Jin

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
16 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2018.
Supervisor on 3 trainee awards (3 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Beta-Catenin Estrogen Gene Expression Glp-1 Gluconeogenesis Insulin Lipid Metabolism Tcf7l2

Latest papers

The use of multi-species probiotic-derived vesicles to encapsulate luteolin for preventing colitis in a mouse model.
iScience · 2026
Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists.
Journal of translational internal medicine · 2025 · senior author
Supplementation of mixed Lactobacillus alleviates metabolic impairment, inflammation, and dysbiosis of the gut microbiota in an obese mouse model.
Frontiers in nutrition · 2025

All 86 publications

Latest funding

A novel direction on exploring metabolic beneficial effect of dietary interventions- involving gut microbiome, the gut hormone GLP-1, and the liver hormone FGF21
CIHR · 2023 · Supervisor
$105,000
Metabolic functions of the Wnt signaling pathway
CIHR · 2018 · Nominated PI
$772,650
The role of transcription factor 7-like 2 (TCF7L2) in hepatic glucose production: Implications to type 2 diabetes mellitus
CIHR · 2012 · Supervisor
$70,000

All 9 grants and awards

86 publications.

The use of multi-species probiotic-derived vesicles to encapsulate luteolin for preventing colitis in a mouse model.

Hou S, Yang H, Wang Q, Zheng X, Li R, He H, Wang L, Zhao T, Shuai Q, Sun Y, Jin T, Liu Z, Xie J

iScience2026

DOI: 10.1016/j.isci.2026.117105 PMID: 42604006

Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists.

Feng J, Jin T

Journal of translational internal medicine2025Senior author

DOI: 10.1515/jtim-2025-0026 PMID: 40896289

Supplementation of mixed Lactobacillus alleviates metabolic impairment, inflammation, and dysbiosis of the gut microbiota in an obese mouse model.

Hou S, Li R, Zhang Y, Liang P, Yang H, He H, Wang L, Sun Y, Jin T, Liu Z, Xie J

Frontiers in nutrition2025

DOI: 10.3389/fnut.2025.1554996 PMID: 40206949

Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice.

Feng JN, Shao W, Yang L, Pang J, Ling W, Liu D, Wheeler MB, He HH, Jin T

Nutrition & diabetes2025Senior author

DOI: 10.1038/s41387-025-00363-0 PMID: 39929809

International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.

Jin T, Chen YE

Cardiovascular drugs and therapy2025First author

DOI: 10.1007/s10557-024-07630-9 PMID: 39470894

Hormone based therapy and crosstalk beyond hormones.

Jin T

Medical review (2021)2024First author

DOI: 10.1515/mr-2024-0052 PMID: 39135606

Hepatic function of glucagon-like peptide-1 and its based diabetes drugs.

Feng JN, Jin T

Medical review (2021)2024Senior author

DOI: 10.1515/mr-2024-0018 PMID: 39135602

Erratum to: A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope.

Wu Z, Jin T, Weng J

Science China. Life sciences2023

DOI: 10.1007/s11427-023-2356-0 PMID: 37410206

Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1.

Pang J, Raka F, Heirali AA, Shao W, Liu D, Gu J, Feng JN, Mineo C, Shaul PW, Qian X, Coburn B, Adeli K, Ling W, Jin T

Nature communications2023Senior author

DOI: 10.1038/s41467-023-38259-1 PMID: 37160898

Commentary: Can FXR serve as a potential target for COVID-19 prevention?

Pang J, Feng JN, Ling W, Jin T

Acta pharmaceutica Sinica. B2023Senior author

DOI: 10.1016/j.apsb.2023.01.023 PMID: 36785699

Something wrong or missing on this profile? Suggest a correction

Tianru Jin

Research

Latest papers

Latest funding

The use of multi-species probiotic-derived vesicles to encapsulate luteolin for preventing colitis in a mouse model.

Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists.

Supplementation of mixed Lactobacillus alleviates metabolic impairment, inflammation, and dysbiosis of the gut microbiota in an obese mouse model.

Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice.

International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.

Hormone based therapy and crosstalk beyond hormones.

Hepatic function of glucagon-like peptide-1 and its based diabetes drugs.

Erratum to: A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope.

Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1.

Commentary: Can FXR serve as a potential target for COVID-19 prevention?

Frequent collaborators

Mingyao Liu

Minna Woo

Zhong-Ping Feng

Hong-Shuo Sun

Khosrow Adeli

Haibo Zhang

Jim Hu

Xiao-Yan Wen

Ian Mcgilvray

Warren Foltz

Naoto Hirano

Bryan Coburn

Daniel Winer

Jianping Weng

Herbert Gaisano

David Spaner

Ren-Ke Li

Chun Peng

Michael Glogauer